Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Crick news > Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery

Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery

Researchers at the Crick and GSK will extend their ongoing collaboration to advance the discovery of new drug targets in a £11.5million effort.
7 Apr 2021
United Kingdom
Crick news

To read this story

Similar stories

A new partnership between the Francis Crick Institute and the British Heart Foundation (BHF) aims to improve understanding of cardiovascular health and disease. More...

Along with 32 other organisations we have co-signed an open letter to the Chancellor about the importance of investing i… More...

Exceptional and motivated undergraduate students at UK universities are invited to apply to the Crick Sandwich Student P… More...

The Crick is proud to open the UK's first exhibition exploring the trail-blazing research that is turning the tide on ca… More...

Carola has moved from the Australian National University, where she was Co-Director of the Centre for Personalised Immun… More...

Have your say

 
This website is powered by
ToucanTech